Primary tabs
The list of publications is indicative and may not include all publications.
Cardiovascular risk in rheumatoid arthritis: assessment, management and next steps..
Ther Adv Musculoskelet Dis. 8(3), 86-101.
(2016).
Imaging Patterns of Cardiovascular Involvement in Mixed Connective Tissue Disease Evaluated by Cardiovascular Magnetic Resonance..
Inflamm Allergy Drug Targets. 14(2), 111-6.
(2015).
Cumulative inflammation associates with asymmetric dimethylarginine in rheumatoid arthritis: a 6 year follow-up study..
Rheumatology (Oxford). 54(7), 1145-52.
(2015).
Symmetric dimethylarginine (SDMA) serum levels in rheumatoid arthritis: correlations with insulin resistance and disease activity scores..
Amino Acids. 47(9), 1995-2004.
(2015).
Molecular and cellular pathways as treatment targets for biologic therapies in systemic sclerosis..
Curr Med Chem. 22(16), 1943-55.
(2015).
Infliximab as a treatment option for patients with rheumatoid arthritis and primary biliary cirrhosis..
Rheumatol Int. 35(11), 1913-6.
(2015).
Individualised exercise improves endothelial function in patients with rheumatoid arthritis..
Ann Rheum Dis. 73(4), 748-51.
(2014).
Osteoarthritis pain has a significant neuropathic component: an exploratory in vivo patient model..
Rheumatol Int. 34(3), 315-20.
(2014).
Asymmetric dimethylarginine is not associated with subendocardial viability ratio in Rheumatoid Arthritis..
Int J Cardiol. 172(1), 285-6.
(2014).
Rheumatoid arthritis: an autoimmune disease with female preponderance and cardiovascular risk equivalent to diabetes mellitus: role of cardiovascular magnetic resonance..
Inflamm Allergy Drug Targets. 13(2), 81-93.
(2014).
Edema and fibrosis imaging by cardiovascular magnetic resonance: how can the experience of Cardiology be best utilized in rheumatological practice?.
Semin Arthritis Rheum. 44(1), 76-85.
(2014).
Cardiac and muscular involvement in idiopathic inflammatory myopathies: noninvasive diagnostic assessment and the role of cardiovascular and skeletal magnetic resonance imaging..
Inflamm Allergy Drug Targets. 13(3), 206-16.
(2014).
Neuropathic pain in osteoarthritis: a review of pathophysiological mechanisms and implications for treatment..
Semin Arthritis Rheum. 44(2), 145-54.
(2014).
Relationship between dimethylarginine dimethylaminohydrolase gene variants and asymmetric dimethylarginine in patients with rheumatoid arthritis..
Atherosclerosis. 237(1), 38-44.
(2014).
Why currently used diagnostic techniques for heart failure in rheumatoid arthritis are not enough: the challenge of cardiovascular magnetic resonance imaging..
Rev Cardiovasc Med. 15(4), 320-31.
(2014).
Micro- and macrovascular treatment targets in scleroderma heart disease..
Curr Pharm Des. 20(4), 536-44.
(2014).
Lack of association between polymorphisms of thrombogenic genes and disease susceptibility in rheumatoid arthritis..
Rheumatol Int. 33(9), 2429-32.
(2013).
Biologic therapies and systemic bone loss in rheumatoid arthritis..
Autoimmun Rev. 12(10), 958-66.
(2013).
Derangement of hemostasis in rheumatoid arthritis: association with demographic, inflammatory and metabolic factors..
Clin Rheumatol. 32(9), 1357-64.
(2013).
Heart involvement in rheumatoid arthritis: multimodality imaging and the emerging role of cardiac magnetic resonance..
Semin Arthritis Rheum. 43(3), 314-24.
(2013).
Clinical outcome of ultrasound-guided steroid injections for chronic shoulder pain..
Int J Rheum Dis. 16(4), 398-402.
(2013).
Systemic sclerosis-related pulmonary hypertension: unique characteristics and future treatment targets..
Curr Pharm Des. 18(11), 1457-64.
(2012).
B-type natriuretic peptide in rheumatic diseases: a cardiac biomarker or a sophisticated acute phase reactant?.
Autoimmun Rev. 11(12), 837-43.
(2012).
Significance of serum uric acid in pulmonary hypertension due to systemic sclerosis: a pilot study..
Rheumatol Int. 31(2), 263-7.
(2011).